Sclerosing melanocytic tumors with MAP2K1 in-frame deletions and copy number gains in 15q: A distinctive pathway of nevogenesis

Authors

Judy Hamad, Henry Ford HealthFollow
Brandon M. Shaw, Henry Ford HealthFollow
Laurie L. Kohen, Henry Ford HealthFollow
K. Linos
Ben J. Friedman, Henry Ford HealthFollow

Recommended Citation

Hamad J, Shaw B, Kohen L, Linos K, and Friedman BJ. Sclerosing melanocytic tumors with MAP2K1 in-frame deletions and copy number gains in 15q: A distinctive pathway of nevogenesis. J Cutan Pathol 2023.

Document Type

Article

Publication Date

4-1-2024

Publication Title

Journal of cutaneous pathology

Medical Subject Headings

Humans; DNA Copy Number Variations; Melanoma; Skin Neoplasms; MAP Kinase Kinase 1

PubMed ID

38149342

ePublication

ePub ahead of print

Volume

51

Issue

4

First Page

284

Last Page

287